Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
26.03
0.39 (1.52%)
At close: May 28, 2025, 3:59 PM
26.26
0.88%
After-hours: May 28, 2025, 07:52 PM EDT
1.52%
Bid 25.96
Market Cap 19.2B
Revenue (ttm) n/a
Net Income (ttm) -240.75M
EPS (ttm) -0.34
PE Ratio (ttm) -76.56
Forward PE -57.44
Analyst Buy
Ask 26.26
Volume 1,719,877
Avg. Volume (20D) 4,001,813
Open 25.66
Previous Close 25.64
Day's Range 25.07 - 26.35
52-Week Range 2.30 - 36.91
Beta -0.95

About SMMT

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SMMT
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SMMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
-36.05%
Summit Therapeutics shares are trading lower. The ... Unlock content with Pro Subscription
1 month ago
+21.5%
Summit Therapeutics shares are trading higher after the company provided updates on its Phase 3 trial of Ivonescimab and announced it met its primary endpoint.